Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
Tamai Y, Hasegawa A, Takamori A, Sasada A, Tanosaki R, Choi I, Utsunomiya A, Maeda Y, Yamano Y, Eto T, Koh KR, Nakamae H, Suehiro Y, Kato K, Takemoto S, Okamura J, Uike N, Kannagi M. Tamai Y, et al. Among authors: suehiro y. J Immunol. 2013 Apr 15;190(8):4382-92. doi: 10.4049/jimmunol.1202971. Epub 2013 Mar 8. J Immunol. 2013. PMID: 23475215
Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study.
Suehiro Y, Hasegawa A, Iino T, Sasada A, Watanabe N, Matsuoka M, Takamori A, Tanosaki R, Utsunomiya A, Choi I, Fukuda T, Miura O, Takaishi S, Teshima T, Akashi K, Kannagi M, Uike N, Okamura J. Suehiro Y, et al. Br J Haematol. 2015 May;169(3):356-67. doi: 10.1111/bjh.13302. Epub 2015 Jan 22. Br J Haematol. 2015. PMID: 25612920 Free article.
[HTLV-1-targeted immunotherapy].
Suehiro Y. Suehiro Y. Rinsho Ketsueki. 2016;57(10):2250-2258. doi: 10.11406/rinketsu.57.2250. Rinsho Ketsueki. 2016. PMID: 27795537 Japanese.
In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
Izaki M, Yasunaga JI, Nosaka K, Sugata K, Utsunomiya H, Suehiro Y, Shichijo T, Yamada A, Sugawara Y, Hibi T, Inomata Y, Akari H, Melamed A, Bangham C, Matsuoka M. Izaki M, et al. Among authors: suehiro y. PLoS Pathog. 2021 Feb 1;17(2):e1009271. doi: 10.1371/journal.ppat.1009271. eCollection 2021 Feb. PLoS Pathog. 2021. PMID: 33524072 Free PMC article.
Clinical significance of tryptophan catabolism in Hodgkin lymphoma.
Masaki A, Ishida T, Maeda Y, Ito A, Suzuki S, Narita T, Kinoshita S, Takino H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Inagaki H, Ueda R, Choi I, Suehiro Y, Iida S. Masaki A, et al. Among authors: suehiro y. Cancer Sci. 2018 Jan;109(1):74-83. doi: 10.1111/cas.13432. Epub 2017 Nov 29. Cancer Sci. 2018. PMID: 29080383 Free PMC article.
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors.
Yoshimitsu M, Fuji S, Utsunomiya A, Nakano N, Ito A, Ito Y, Miyamoto T, Suehiro Y, Kawakita T, Moriuchi Y, Nakamae H, Kanda Y, Ichinohe T, Fukuda T, Atsuta Y, Kato K; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Yoshimitsu M, et al. Among authors: suehiro y. Biol Blood Marrow Transplant. 2020 Apr;26(4):718-722. doi: 10.1016/j.bbmt.2019.12.004. Epub 2019 Dec 9. Biol Blood Marrow Transplant. 2020. PMID: 31821886 Free article.
365 results